Full-Time

Research Engineer

PDT Partners

PDT Partners

201-500 employees

Quantitative asset management via algorithmic trading

Compensation Overview

$190k - $250k/yr

New York, NY, USA

Hybrid

Three days on-site per week required.

Category
AI & Machine Learning (1)
Required Skills
Neural Networks
Machine Learning

Get referred to PDT Partners

See people who can refer or advise you

Requirements
  • In-depth knowledge of machine learning techniques and deep learning ecosystem to help build infrastructure capable of supporting complex scientific research at scale.
  • Must be able to work from the New York City office at least 3 days per week (hybrid position).
Responsibilities
  • Partner with the research team to understand future research directions and build the next generation of highly scalable infrastructure for alpha, signal, and portfolio construction.
  • Incorporate advancements in machine learning, hardware accelerators and high-performance computing to optimize research workflows.
  • Maintain, develop, and re-imagine the extensive internal research stack that continues to be a differentiating factor for PDT business.
  • Optimize models for inference and use in real time trading systems.
Desired Qualifications
  • Experience with building infrastructure for training/fine-tuning large machine learning models.
  • Intellectual curiosity and a strong interest in solving difficult problems.
  • Exceptional programming skills and proficiency in identifying performance bottlenecks.
  • Experience with the Python scientific stack and deep learning libraries (PyTorch, TensorFlow, etc.).
  • Experience with hardware accelerators.
  • Previous experience in Quant Finance is not required.

PDT Partners uses quantitative models to identify market inefficiencies and predict price moves, delivering algorithmic trading strategies for institutional clients. Its models analyze vast market data to detect patterns, then execute trades automatically with precision. It differentiates itself through a long history in quantitative investing since the 1990s, a culture of empirical validation, scientific research, and a collaborative environment that rigorously tests ideas before deployment. The goal is to generate investment returns for clients by systematically exploiting market inefficiencies with disciplined, data-driven trading.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

1993

Get referred to PDT Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • PDT posted fresh openings on September 4, 2026, including Applied ML Scientist.
  • Its 2026-Q1 13F reported 526 long positions worth $1.7 billion.
  • PDT reduced its Invisio short below 0.5 percent on August 7, 2026.

What critics are saying

  • PDT’s secrecy leaves job seekers blind to turnover, PnL, and strategy decay.
  • Public filings show no recent external capital; talent competition stays brutal versus Citadel.
  • A bad multi-year research edge collapse would force asset runoff and layoffs by 2027.

What makes PDT Partners unique

  • PDT combines systematic trading, execution, and risk control under one research organization.
  • The firm still hires PhD-heavy researchers and engineers in New York and London.
  • PDT’s internal research stack and collaborative model separate it from pod shops.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Full medical, dental, vision, disability, and life insurance coverage

Wellness perks and programs

Generous time off and unlimited sick leave

Match charitable giving

Subsidize fitness and exercise

Emergency back-up child and elder care

401k matching and pre-tax benefits

Company News

Ticker Report
Aug 27th, 2026
PDT Partners LLC Makes New $3.35 Million Investment in West Pharmaceutical Services, Inc. $WST

PDT Partners LLC bought a new stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) during the 2nd quarter, Holdings Channel reports. The fund bought 9,332 shares of the medical instruments supplier’s stock, valued at approximately $3,350,000. A number of other institutional investors also recently bought and sold shares of the stock. […]

Bloomberg
Dec 4th, 2025
The Hedge Fund That Hides Secrets on the Office Walls

The hedge fund that hides secrets on the office walls. Founder Pete Muller has a passion for puzzles, so he turned the company's headquarters into a cryptic challenge. When quantitative hedge fund PDT Partners moved into its new headquarters in New York City after the pandemic, Chief Executive Officer Pete Muller wanted to entice employees back into the office. So he designed a puzzle. "I wanted to give them a reason to look around," he says. About 80 artworks are displayed around the three-floor office in Columbus Circle, five of which contain cryptic clues to a phrase. (Gotham Immersive Laboratories helped with the puzzle designs.) Shortly after the challenge was announced at a companywide meeting, Winnie Yang, an engineer, teamed up with a colleague to locate and photograph all the artworks.

ETFDailyNews.com
Sep 21st, 2025
NorthCrest Asset Manangement LLC Sells 713 Shares of Target Corporation $TGT

Finally, PDT Partners LLC purchased a new stake in Target in the 1st quarter worth approximately $4,623,000.

ETFDailyNews.com
May 26th, 2025
International Money Express, Inc. (NASDAQ:IMXI) Receives $20.50 Consensus Price Target from Brokerages

PDT Partners LLC purchased a new stake in International Money Express in the 1st quarter worth about $464,000.

ETFDailyNews.com
Mar 29th, 2025
Intech Investment Management LLC Boosts Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT)

PDT Partners LLC purchased a new stake in 2seventy bio in the 3rd quarter valued at about $244,000.